FAQ

Frequently Asked Questions

What is autocrine signaling?

Autocrine signaling is a form of cell communication in which a cell releases a signaling molecule that binds to receptors on its own surface (or, in some cases, inside the cell) and triggers a response in that same cell.

How is it different from paracrine and endocrine signaling?

In paracrine signaling the signal acts on nearby, different cells; in endocrine signaling hormones travel through the bloodstream to distant targets; in juxtacrine signaling the signal requires direct cell-to-cell contact. Many molecules can act in more than one mode. See the comparison article.

What are classic examples of autocrine signaling?

Well-known examples include interleukin-2 (IL-2) driving the proliferation of the activated T cells that produce it, and tumour cells that produce growth factors such as TGF-alpha while also expressing the matching receptor (EGFR).

Why is autocrine signaling important in cancer?

Self-sufficiency in growth signals is a hallmark of cancer. Tumour cells can create autocrine loops that keep growth and survival pathways switched on without external signals; some targeted therapies aim to block these loops.

What is intracrine signaling?

Intracrine signaling describes a molecule that acts inside the cell that made it, without being secreted, for example some steroid-derived signals. It is sometimes grouped with autocrine signaling.

Does autocrine.com give medical advice?

No. The site is purely educational and cannot answer personal medical or treatment questions. See the disclaimer.

Can I use this site for coursework?

You are welcome to read and link to the articles. For academic work, please cite textbooks and the primary literature (for example via PubMed), because the articles here are summaries and are not peer reviewed.

Who runs the site?

autocrine.com is an independent educational website and is not affiliated with any university, hospital or company. See the About page.

How do I report an error?

Please use the contact form. Corrections are welcome.